Establishment Labs Holdings (ESTA) Receivables (2017 - 2026)
Establishment Labs Holdings' (ESTA) quarterly Receivables came in at $77.1 million in Q1 2026, up 21.89% year-on-year from $63.2 million in Q1 2025, and down 0.54% quarter-over-quarter from $77.5 million in Q4 2025.
Establishment Labs Holdings (ESTA) Receivables (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Receivables history runs 10 years deep, the most recent figure standing at $77.1 million for Q1 2026.
- On a quarterly basis, Receivables rose 21.89% year-over-year to $77.1 million in Q1 2026; TTM through Mar 2026 was $77.1 million, a 21.89% increase from a year earlier, with the FY2025 full-year figure at $77.5 million, up 19.22% from the prior year.
- Receivables eased to $77.1 million in Q1 2026 per ESTA's latest filing, from $77.5 million in the prior quarter.
- Across five years, Receivables topped out at $77.5 million in Q4 2025 and bottomed at $30.2 million in Q1 2022.
- The 5-year median for Receivables is $56.4 million (2023), against an average of $54.6 million.
- Across the five-year window, Receivables jumped 78.76% in 2023 and gained 6.23% in 2025, its largest moves.
- Year by year, Receivables stood at $35.4 million in 2022, then surged by 32.45% to $46.9 million in 2023, then soared by 38.54% to $65.0 million in 2024, then climbed by 19.22% to $77.5 million in 2025, then fell by 0.54% to $77.1 million in 2026.
- Per Business Quant, the three latest ESTA Receivables figures stand at $77.1 million (Q1 2026), $77.5 million (Q4 2025), and $71.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 8.21 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.57 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 6.64 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 3.03 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 973.00 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.11 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.80 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 4.50 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.55 Bn |
| 10 | Establishment Labs Holdings | 2.73 Bn | 2.66 Bn | 42.34 Mn | 77.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 77.08 Mn |
| Dec 31, 2025 | 77.50 Mn |
| Sep 30, 2025 | 71.44 Mn |
| Jun 30, 2025 | 70.09 Mn |
| Mar 31, 2025 | 63.24 Mn |
| Dec 31, 2024 | 65.00 Mn |
| Sep 30, 2024 | 67.25 Mn |
| Jun 30, 2024 | 59.98 Mn |
| Mar 31, 2024 | 50.84 Mn |
| Dec 31, 2023 | 46.92 Mn |
| Sep 30, 2023 | 56.39 Mn |
| Jun 30, 2023 | 51.40 Mn |
| Mar 31, 2023 | 41.85 Mn |
| Dec 31, 2022 | 35.42 Mn |
| Sep 30, 2022 | 31.55 Mn |
| Jun 30, 2022 | 32.30 Mn |
| Mar 31, 2022 | 30.19 Mn |
| Dec 31, 2021 | 24.84 Mn |
| Sep 30, 2021 | 24.90 Mn |
| Jun 30, 2021 | 23.39 Mn |